SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030145
Filing Date
2023-06-27
Accepted
2023-06-27 16:35:06
Documents
12
Period of Report
2023-06-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K acor-20230622.htm   iXBRL 8-K 85208
  Complete submission text file 0000950170-23-030145.txt   204317

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20230622.xsd EX-101.SCH 2463
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20230622_lab.xml EX-101.LAB 13360
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20230622_pre.xml EX-101.PRE 9839
6 EXTRACTED XBRL INSTANCE DOCUMENT acor-20230622_htm.xml XML 4711
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 231047856
SIC: 2836 Biological Products, (No Diagnostic Substances)